Principles of Cancer Therapy

  • Gunter Deppe
  • Pamela E. Smith


Surgery, radiation, and chemotherapy encompass the major treatment modalities utilized in the therapy of malignant diseases. Although treatment principles vary little between the gravid and nongravid patient,1–5 there are a number of special considerations to be taken into account when choosing and designing a therapeutic regimen for the pregnant patient with cancer.


Necrotizing Fasciitis Antineoplastic Agent Linear Energy Transfer Hemorrhagic Cystitis Nitrogen Mustard 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boronow RC: Extrapelvic malignancy and pregnancy. Obstet Gynecol Surv 19: 1–29, 1964PubMedCrossRefGoogle Scholar
  2. 2.
    DiSaia PJ, Creasman WT: Cancer in pregnancy, in DiSaia PJ, Creasman WT (eds): Clinical Gynecologic Oncology. St Louis, CV Mosby, 1981, pp 376–400Google Scholar
  3. 3.
    Roberts JA: Management of gynecologic tumors during pregnancy. Clin Perinatol 10: 369–382, 1983PubMedGoogle Scholar
  4. 4.
    Boronow RC: Extrapelvic malignancy in pregnancy, in Barber HRK, Graber EA (eds): Surgical Disease in Pregnancy. Philadelphia, WB Saunders, 1974, pp 691–705Google Scholar
  5. 5.
    Barber HRK: Malignant disease in the pregnant woman, in Coppleson M (ed): Gynecologic Oncology: Fundamental Principles and Clinical Practice. Edinburgh, Churchill Livingstone, 1981, pp 795–806Google Scholar
  6. 6.
    Wharton JT, Fletcher GH: The principle of radiation therapy for malignant pelvic lesions. Surg Clin North Am 58: 181–199, 1978PubMedGoogle Scholar
  7. 7.
    Hellman S: Principles of radiation therapy, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer-Principles and Practice on Oncology. Philadelphia, JB Lippincott, 1982, pp 103–131Google Scholar
  8. 8.
    Ritter MA: The radiobiology of mammalian cells. Semin Oncol 8: 3–17, 1981PubMedGoogle Scholar
  9. 9.
    Smith PG, Doll R: Late effects of X-irradiation in patients healed for metropathia hemorrhagica. Br J Radiol 49: 224–232, 1976PubMedCrossRefGoogle Scholar
  10. 10.
    Boice JD, Hutchinson GB: Leukemia in women following radiotherapy for cervical cancer: Ten year follow up of an international study. J Natl Cancer Inst 65: 115–129, 1980PubMedGoogle Scholar
  11. 11.
    Baserga R: The cell cycle. N Engl J Med 304: 453–459, 1981Google Scholar
  12. 12.
    DeVita VT Jr: Principles of chemotherapy, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer-Principles and Practice of Oncology. Philadelphia, JB Lippincott, 1982, pp 132–155Google Scholar
  13. 13.
    Krakoff IH: Cancer Chemotherapeutic Agents. Washington, American Cancer Society, 1977Google Scholar
  14. 14.
    Perry MC: Chemotherapy, toxicity, and the clinician. Semin Oncol 9: 1–4, 1982PubMedGoogle Scholar
  15. 15.
    Nicholson HO: Cytotoxic drugs in pregnancy. J Obstet Gynaecol Br Commonw 75: 307–312, 1968PubMedCrossRefGoogle Scholar
  16. 16.
    Sokal JE, Lessmann EM: Effects of cancer chemotherapeutic agents on the human fetus. JAMA 172: 1765–1771, 1960Google Scholar
  17. 17.
    Gililland J, Weinstein L: The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 38: 6–13, 1983PubMedGoogle Scholar
  18. 18.
    Roboz J, Gleicher N, Wu K, et al: Does doxorubicin cross the placenta? Lancet 2: 1382–1383, 1979PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Gunter Deppe
  • Pamela E. Smith

There are no affiliations available

Personalised recommendations